• Home
  • NEW DAY MEDICINE
  • 3 (65) 2024
  • 41 -3 (65) 2024 - Davronova H.Z. - THE SIGNIFICANCE OF CHRONIC CEREBRAL CIRCULATION DISORDERS AND THE DEVELOPMENT OF COGNITIVE DYSFUNCTION IN PATIENTS WITH TYPE II DIABETES

41 -3 (65) 2024 - Davronova H.Z. - THE SIGNIFICANCE OF CHRONIC CEREBRAL CIRCULATION DISORDERS AND THE DEVELOPMENT OF COGNITIVE DYSFUNCTION IN PATIENTS WITH TYPE II DIABETES

THE SIGNIFICANCE OF CHRONIC CEREBRAL CIRCULATION DISORDERS AND THE DEVELOPMENT OF COGNITIVE DYSFUNCTION IN PATIENTS WITH TYPE II DIABETES

Davronova H.Z. Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Cerebrovascular diseases are an important medico-social problem, which causes a lot of death and disability, and is currently becoming an economic problem with high costs. Diabetes mellitus is one of the main risk factors for cerebral ischemic stroke. Today, diabetes mellitus is among the diseases that are widespread among the working population, developing and leading to serious systemic complications. Among all endocrine pathologies, diabetes mellitus (DM) ranks first in terms of prevalence, death and disability.

Keywords: diabetes, cognitive dysfunction, moderate stenosis of BSA

First page

215

Last page

221

For citation: Davronova H.Z. - THE SIGNIFICANCE OF CHRONIC CEREBRAL CIRCULATION DISORDERS AND THE DEVELOPMENT OF COGNITIVE DYSFUNCTION IN PATIENTS WITH TYPE II DIABETES//New Day in Medicine 3(65)2024 215-221 https://newdayworldmedicine.com/en/article/3758

List of References

  1. Abbatecola A.M., Rizzo M.R., Barbieri M. et al. Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics // Neurology, 2006; 67: 235–240.
  2. Alafuzoff I., Aho L., Helisalmi S. et al. β-Amyloid deposition in brains of subjects with diabetes // Neuropathol. Appl. Neurobiol., 2009; 35: 60–68.
  3. Arvanitakis Z. et al. Diabetes is related to cerebral infarction but not to AD pathology in older persons // Neurology, 2006; 67: 1960–1965.
  4. Beeri M. et al. Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology // Neurology, 2008; 71: 750–757.
  5. Biessels G.J., Staekenborg S., Brunner E., et al. Risk of dementia in diabetes mellitus: a systematic review // Lancet Neurol., 2006; 5: 64–74.
  6. Craft S. The Role of Metabolic Disorders in Alzheimer Disease and Vascular Dementia // Arch. Neurol., 2009. – V. 66. – P. 300–305. 13. DCCT/EDIC Study Recearch Group. Long-Term effect of diabetes and its treatment on cognitive function // New Engl. J. Med., 2007; 356: 1842–1852.
  7. Irie F., Fitzpatrick A.L., Lopez O.L. Enhanced Risk for Alzheimer Disease in Persons With Type 2 Diabetes and APOE-4 // Arch. Neurol., 2008; 65: 89–93.
  8. Kalaria R.N. Diabetes, microvascular pathology and Alzheimer disease // Nature Rev. Neurology, 2009; 5: 305–306.
  9. Рахматова Д. И., Пулатов С. С. (2016). Особенности течения инволюционной эпилепсии. // Биология и интегративная медицина 2016; (1):70-82.
  10. Ismatilloyevna R. D. (2022). The effectiveness of neuroprotective therapy in ischemic stroke. // European journal of modern medicine and practice, 2022; 2(1): 17-21.
  11. Рахматова Д. И. (2019). Нетрадиционные методы терапии невропатии лицевого нерва на разных этапах развития заболевания. // Проблемы биологии и медицины, 2019; 2(107):180-183.
  12. Рахматова Д. И. (2022). Новые Возможности Оценки Лечения У Больных С Невропатией Лицевого Нерва Коморбидных С Сахарным Диабетом. // Amaliy va tibbiyot fanlari ilmiy jurnali, 2022; 1(7): 38-43.
  13. Рахматова Д. И. (2021). Значение нейровизуализационного метода ислледования в диагностике осложнённых форм невропатии лицевого нерва. // Журнал неврологии и нейрохирургических исследований, 2021; 2(3).
  14. Саломова, Н. К. (2021). Особенности течения и клинико-патогенетическая характеристика первичных и повторных инсультов. // Central Asian Journal of Medical and Natural Science, 2021; 249-253.
  15. Саломова Н. Қ. (2023). Қайта ишемик инсультларнинг клиник потогенитик хусусиятларини аниқлаш. // Innovations in Technology and Science Education, 2023; 2(8): 1255-1264.
  16. Salomova, N. K. (2022). Risk factors for recurrent stroke. // Polish journal of science 2022; 52: 33-35.
  17. Qahharovna S. N. (2023). Thromboocclusive Lesions of the Bronchocephalic Arteries: Treatment Options and Phytotherapy Options. // American journal of science and learning for development, 2023; 2(2): 41-46.
  18. Salomova Nilufar Kakhorovna Features of neurorehabilitation itself depending on the pathogenetic course of repeated strokes, localization of the stroke focus and the structure of neurological deficit // European Journal of Research Development and Sustainability (EJRDS 11. 8-12. 2022/11
  19. Salomova N. K. (2022). Risk factors for recurrent stroke. Polish journal of science 2022; 52:33-35.
  20. Гаффарова В.Ф. Способ прогнозирования психо-речевых нарушений при фебрильных судорогах у детей. / Методическая рекомендация. 2021;18c.

    file

    download